secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001564590-21-039644
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharma announces resignation of Principal Accounting Officer, appoints Paul Little as successor
--------------------------------------------------------------------------------

- Jon Kuwahara resigned as SVP, Finance & Administration and Principal Accounting Officer effective July 31, 2021.
- Paul Little, current CFO and Principal Financial Officer, appointed as Principal Accounting Officer effective same date.
- No family relationships or arrangements were disclosed in connection with the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/0001564590-21-039644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000156459021039644/eldn-8k_20210731.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-039644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer